AAAAAA

   
Results: 1-5 |
Results: 5

Authors: Rieman, DJ McClung, HA Dodds, RA Hwang, SM Lark, MW Holmes, S James, IE Drake, FH Gowen, M
Citation: Dj. Rieman et al., Biosynthesis and processing of cathepsin K in cultured human osteoclasts, BONE, 28(3), 2001, pp. 282-289

Authors: Dodds, RA James, IE Rieman, D Ahern, R Hwang, SM Connor, JR Thompson, SD Veber, DF Drake, FH Holmes, S Lark, MW Gowen, M
Citation: Ra. Dodds et al., Human osteoclast cathepsin K is processed intracellularly prior to attachment and bone resorption, J BONE MIN, 16(3), 2001, pp. 478-486

Authors: Miller, WH Bondinell, WE Cousins, RD Erhard, KF Jakas, DR Keenan, RM Ku, TW Newlander, KA Ross, ST Haltiwanger, RC Bradbeer, J Drake, FH Gowen, M Hoffman, SJ Hwang, SM James, IE Lark, MW Lechowska, B Rieman, DJ Stroup, GB Vasko-Moser, JA Zembryki, DL Azzarano, LM Adams, PC Salyers, KL Smith, BR Ward, KW Johanson, KO Huffman, WF
Citation: Wh. Miller et al., Orally bioavailable nonpeptide vitronectin receptor antagonists with efficacy in an osteoporosis model, BIOORG MED, 9(13), 1999, pp. 1807-1812

Authors: Lark, MW Stroup, GB Hwang, SM James, IE Rieman, DJ Drake, FH Bradbeer, JN Mathur, A Erhard, KF Newlander, KA Ross, ST Salyers, KL Smith, BR Miller, WH Huffman, WF Gowen, M
Citation: Mw. Lark et al., Design and characterization of orally active Arg-Gly-Asp peptidomimetic vitronectin receptor antagonist SB 265123 for prevention of bone loss in osteoporosis, J PHARM EXP, 291(2), 1999, pp. 612-617

Authors: Dodds, RA Connor, JR Drake, FH Gowen, M
Citation: Ra. Dodds et al., Expression of cathepsin K messenger RNA in giant cells and their precursors in human osteoarthritic synovial tissues, ARTH RHEUM, 42(8), 1999, pp. 1588-1593
Risultati: 1-5 |